ClinicalTrials.gg
CompletedNCT07893756SDFUpdated Oct 26, 2026

Evaluation of Silver Diamine Fluoride, Sodium Fluoride With Casein Phosphopeptide-Amorphous Calcium Phosphate(MI Varnish) and Dycal to Arrest Caries When Used in Indirect Pulp Capping Procedures in Children

A Phase 2 interventional study of Silver Diamine Fluoride (SDF, 38%) gel and Sodium Fluoride with CPP-ACP (MI varnish) in Early Childhood Caries (ECC), Color Stability of Restoration and Caries Arrested, sponsored by University of Jazan. Completed at 1 site in Saudi Arabia. Open to participants aged 3 Years to 9 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by University of Jazan · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 5 months after the study started (first participant enrolled May 2024, registered Oct 2026).
Updated Oct 26, 2026Newly registeredGo to Updates ↓
Phase
Phase 2
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
3 Years to 9 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 26 studies testing silver diamine fluoride in Dental Caries — 4 open to participants now, 4 under way, none of them phase 3. silver diamine fluoride · Dental Caries.

Enrollment
9th of 26
90 · median 60
Started
2024
with 2 others
Phase 2
6 of 26
none open now
Registered
25th of 26
by date
Lead sponsor
2 of 26
University of Jazan

Among the 26 studies testing silver diamine fluoride in Dental Caries, this one is the 9th largest by enrollment, is one of 3 that started in 2024, is one of 6 in phase 2, and was the 25th registered.

By phase

26 studies; the count open now beside each. This study's row is marked.

No phase6 · 2 open
Phase 2this study6 · 0 open
Phase 46 · 2 open
Phase 2/35 · 0 open
Phase 32 · 0 open
Phase 11 · 0 open

By the year they started

First in 2012; this study’s year is marked. 3 started in 2024.

Size and results

Median enrollment 60 across the 26 interventional studies. Of the 16 that completed or were terminated, 5 (31%) have results posted.

Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 26 studies testing silver diamine fluoride in Dental Caries, or all of them as a file.
02

Study summary

Early childhood caries is a serious public health issue often neglected and goes untreated having detrimental effects on the child and their family. Hence, multiple teeth are affected with dental caries approaching close to pulp. Unfortunately, there is insufficient clinical studies evidence to demonstrate the indirect pulp capping efficacy of the available remineralizing dental materials and the color stability of restorations placed over them over a period of time.

Read the detailed description

Children from 3 to 6 years age having Early Childhood Caries, and children from 6-9 years will undergo indirect pulp treatment in teeth showing signs of irreversible pulpitis.

This randomized controlled clinical trial will evaluate and compare the efficacy of SDF gel+ KI , NaF + CPP- ACP (MI varnish) and dycal as indirect pulp capping procedures in children. In addition, data was collected to assess the color stability of the aesthetic restorations following the application of these pulp capping materials.

03

Conditions studied

  • Early Childhood Caries (ECC)
  • Color Stability of Restoration
  • Caries Arrested
  • Caries,Dental

Browse trials for

Keywords

  • SILVER DIAMINE FLUORIDE
  • Indirect pulp capping
04

Who can participate

Ages eligible
3 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged between 3 to 9 years
  • Presenting with at least one untreated cavitated active Class I carious lesion in a primary mandibular second molar were considered for inclusion. Diagnosis of carious lesions was based on Nyvad's clinical criteria (Level 3), indicating dentinal involvement without pulp exposure or symptoms of irreversible pulpitis, which was confirmed with an intra-oral periapical radiograph.
  • Only systemically healthy children, as confirmed by medical history, were included.

Exclusion criteria

Exclusion Criteria:

  • Children with irreversible pulpitis, spontaneous pain, periapical abscess, sinus tract, fistula, or tooth mobility were excluded from the study.
  • Those with special healthcare needs or systemic illnesses Children of whose parents declined consent, were also excluded.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    cavitated caries lesions involving enamel and dentin but not pulp with experimental drugs

    Reversible pulpitis

    Drug: Silver Diamine Fluoride (SDF, 38%) gel · Drug: Sodium Fluoride with CPP-ACP (MI varnish)

  • Active comparator
    cavitated caries lesions involving enamel and dentin but not pulp with Calcium hydroxide

    Reversible pulpitis

    Drug: Calcium Hydroxide (CH)

Interventions

06

What researchers measure

Primary outcomes

  1. Clinical assessment of pulpitis to determine success of indirect pulp capping procedure

    All teeth after intervention will be clinically assessed for success of pulp capping procedure. Clinical assessment of pulpitis was done based on following criteria * Tenderness to percussion or palpation * Tooth mobility * Signs of soft tissue inflammation, sinus tract, or fistula formation * Presence or absence of postoperative pain If the tooth is asymptomatic with no signs of pulpitis , then the tooth is recorded as treatment positive. If any tooth shows any above signs of pulpitis it will be evaluated as treatment negative.

    Time frame: The outcomes will be clinically assessed from the date of intervention up to 3 months for success of pulp capping procedure.

  2. Assessment of color stability of restorations placed after indirect pulp capping procedure

    Color evaluation of the carious site was performed using both an intraoral spectrophotometer (VITA Easyshade® Advance) and a smartphone-based digital system (Chromatcher) using CIELAB( all perceptible colors using three values) scores . The change in visual perception was calculated with the Delta E (▲E) values for both Spectrophotometer and Smartphone- based digital system.

    Time frame: The outcome will be assessed before intervention, immediately after placing the restoration up to 3 months using both Spectrophotometer and Smartphone- based digital system.

07

Study locations

1 site
  • College of Dentistry, Jazan University
    Jizan, Jazan Region 45142, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No — There is no plan to share the IPD because the study can be continued for long term in future

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07893756
Lead sponsor
University of Jazan
Responsible party
Dr Renuga Lakshmi (Assistant Professor, University of Jazan) — Principal investigator
First posted
Oct 26, 2026
Start date
May 6, 2024
Primary completion
Jun 2, 2025
Completion
Jun 16, 2026
Last update
Oct 26, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Silver diamine fluoride · Sodium Fluoride · Casein phosphopeptide-amorphous calcium phosphate nanocomplex

Start the discussion